Galantamine Hydrobromide

Galantamine Hydrobromide is a tertiary alkaloid originally isolated from the bulbs of Galanthus woronowii and other Amaryllidaceae species. As a reversible, competitive acetylcholinesterase inhibitor, it is widely used in the treatment of mild to moderate Alzheimer’s disease and other cognitive disorders. Our product is produced via semi-synthesis or extraction, purified to ≥98% (HPLC), and supplied as a white to off-white crystalline powder.

This API is intended for pharmaceutical formulations, including tablets, capsules, and oral solutions. Each batch is accompanied by a comprehensive COA, MSDS, and TDS, ensuring full traceability and regulatory compliance.

Synonyms: Galantamine HBr, (4aS,6R,8aS)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide, Razadyne, Reminyl, Nivalin

Applications

• Pharmaceutical formulations for cognitive enhancement and Alzheimer’s disease treatment
• Research and development in neuropharmacology
• Compounding pharmacies for customized dosage forms

Quality & Documentation

Every batch is tested for assay (HPLC ≥98%), loss on drying (≤0.5%), and heavy metals (≤10 ppm). Full COA, MSDS, and TDS are available on request; stability data can be provided for qualification.

Packaging & Supply

Standard packaging: 1 kg, 5 kg, 25 kg; bulk and custom packing available. In-stock items ship within 3-5 days; MOQ from 1 kg. For pricing, samples, and bulk orders, contact our sales team.

Request For Quote

• Our Address: 280 Main Street, Xian, Shaanxi, China
• LyvBio Co., Ltd. — Email: info@lyvbio.com